MX2009006088A - Nanoemulsion. - Google Patents
Nanoemulsion.Info
- Publication number
- MX2009006088A MX2009006088A MX2009006088A MX2009006088A MX2009006088A MX 2009006088 A MX2009006088 A MX 2009006088A MX 2009006088 A MX2009006088 A MX 2009006088A MX 2009006088 A MX2009006088 A MX 2009006088A MX 2009006088 A MX2009006088 A MX 2009006088A
- Authority
- MX
- Mexico
- Prior art keywords
- nanoemulsion
- present
- diseases
- composition
- alcohol
- Prior art date
Links
- 239000007908 nanoemulsion Substances 0.000 title abstract 5
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical group NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 229960002749 aminolevulinic acid Drugs 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/21—Emulsions characterized by droplet sizes below 1 micron
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
Abstract
La presente invención se relaciona con una nanoemulsión que comprende por lo menos un componente acuoso y un portador, en donde el portador comprende por lo menos un componente lipofílico, por lo menos un tensioactivo y por lo menos un alcohol, caracterizado porque por lo menos un alcohol tiene por lo menos tres átomos de carbono. La presente invención se relaciona adicionalmente con una composición que comprende dicha nanoemulsión y un agente activo. En particular, la composición está presente como un gel y el agente activo es ácido 5-aminolevulínico, un derivado, precursor y/o metabolito del mismo. La invención se relaciona adicionalmente con la preparación de la nanoemulsión y/o composición y con su uso para el tratamiento de enfermedades dermatológicas, enfermedades asociadas a virus así como enfermedades asociadas con proliferación celular, en particular, enfermedades tumorales y/o psoriasis. La presente invención se relaciona adicionalmente con el uso de dicha nanoemulsión en cosméticos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06026698A EP1938801A1 (en) | 2006-12-22 | 2006-12-22 | Nanoemulsion |
| PCT/EP2007/011404 WO2008077641A1 (en) | 2006-12-22 | 2007-12-21 | Nanoemulsion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009006088A true MX2009006088A (es) | 2009-08-28 |
Family
ID=38042639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009006088A MX2009006088A (es) | 2006-12-22 | 2007-12-21 | Nanoemulsion. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11540981B2 (es) |
| EP (2) | EP1938801A1 (es) |
| JP (1) | JP5558827B2 (es) |
| CN (1) | CN101588792B (es) |
| AR (1) | AR064659A1 (es) |
| AU (1) | AU2007338323B2 (es) |
| BR (1) | BRPI0720853A2 (es) |
| CA (1) | CA2670715C (es) |
| CL (1) | CL2007003730A1 (es) |
| ES (1) | ES2602107T3 (es) |
| IL (1) | IL198934A (es) |
| MX (1) | MX2009006088A (es) |
| NZ (1) | NZ577061A (es) |
| RU (1) | RU2491917C2 (es) |
| UA (1) | UA101471C2 (es) |
| UY (1) | UY30833A1 (es) |
| WO (1) | WO2008077641A1 (es) |
| ZA (1) | ZA200903468B (es) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
| MX2009005727A (es) | 2006-12-01 | 2009-08-27 | Anterios Inc | Nanoparticulas de entidad anfifilica. |
| WO2008140594A2 (en) | 2006-12-01 | 2008-11-20 | Anterios, Inc. | Peptide nanoparticles and uses therefor |
| EP1938801A1 (en) * | 2006-12-22 | 2008-07-02 | Biofrontera Bioscience GmbH | Nanoemulsion |
| EP2162117B1 (en) | 2007-05-31 | 2018-02-21 | Anterios, Inc. | Nucleic acid nanoparticles and uses therefor |
| JP2010143848A (ja) * | 2008-12-18 | 2010-07-01 | Kao Corp | 化粧料 |
| CN101874795A (zh) * | 2009-04-28 | 2010-11-03 | 上海复旦张江生物医药股份有限公司 | 5-氨基酮戊酸在制备治疗hpv病毒感染的药物的用途 |
| JP2013502436A (ja) * | 2009-08-21 | 2013-01-24 | ターゲッティド デリバリー テクノロジーズ リミテッド | 小胞状の製剤 |
| US20110200645A1 (en) * | 2010-02-18 | 2011-08-18 | Martek Biosciences Corporation | DHA Free Fatty Acid Emulsions |
| US20110206741A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | DHA Triglyceride Emulsions |
| US20110200644A1 (en) * | 2010-02-18 | 2011-08-18 | Martek Biosciences Corporation | DHA Ester Emulsions |
| DE202010004750U1 (de) | 2010-04-09 | 2011-10-11 | Biofrontera Bioscience Gmbh | Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut |
| KR20130028967A (ko) * | 2010-06-23 | 2013-03-20 | 브라잇사이드 이노베이션스 인크. | 레시틴 캐리어 베시클 및 이의 제조 방법 |
| BRPI1002486B1 (pt) * | 2010-07-22 | 2017-07-18 | Evidence Soluções Farmacêuticas Ltda Epp | Stabilized topical composition and process of obtaining composition stable topic |
| JP2012051823A (ja) * | 2010-08-31 | 2012-03-15 | Fujifilm Corp | 難容性薬物含有水中油型乳化組成物及びその製造方法 |
| WO2012035747A1 (ja) * | 2010-09-14 | 2012-03-22 | 学校法人東京農業大学 | がん温熱療法の作用増強剤 |
| PH12013500783A1 (en) | 2010-10-21 | 2022-03-30 | Cadila Healthcare Ltd | Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis |
| US9789123B2 (en) | 2010-10-21 | 2017-10-17 | Cadila Healthcare Limited | Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis |
| CN103327964B (zh) * | 2010-12-10 | 2018-06-29 | Ns技术私人有限公司 | 形成细乳液的方法以及所述细乳液用于递送生物活性作用剂的用途 |
| WO2012086802A1 (ja) | 2010-12-24 | 2012-06-28 | アークレイ株式会社 | 癌細胞の検出方法 |
| DE102010056192A1 (de) | 2010-12-28 | 2012-06-28 | Gabriele Blume | Kolloidales Trägersystem mit penetrierenden Eigenschaften zum Einschließen lipophiler Wirkstoffe und Öle für die topische Anwendung |
| IL293156A (en) * | 2011-01-24 | 2022-07-01 | Anterios Inc | Nanoparticle compounds, their formulations, and their use |
| FR2977801B1 (fr) * | 2011-07-11 | 2013-08-16 | Fabre Pierre Dermo Cosmetique | Dispositif et procede pour la sterilisation a ultra-haute temperature d'une emulsion, notamment dermo-cosmetique, instable a la temperature de sterilisation |
| DK2804587T3 (da) | 2012-01-19 | 2019-08-12 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Formulering og fremgangsmåde til øgning af lægemidlers biotilgængelighed |
| CN102600178A (zh) * | 2012-03-08 | 2012-07-25 | 西北农林科技大学 | 一种复方盐酸布替萘芬纳米乳及其制备方法 |
| GB201205642D0 (en) | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
| JP2015516411A (ja) | 2012-05-10 | 2015-06-11 | ペインレフォーム リミテッド | 疎水性有効成分のデポー製剤及びその調製方法 |
| GB201208409D0 (en) * | 2012-05-14 | 2012-06-27 | Sequessome Technology Holdings Ltd | Vesicular formulations, kits and uses |
| JP6112498B2 (ja) * | 2012-07-20 | 2017-04-12 | 株式会社 Ｍ Ｌａｂｓ | 防腐剤・界面活性剤フリーの化粧品原料液、化粧品及び化粧品原料液の調製法 |
| US10137085B2 (en) | 2014-03-19 | 2018-11-27 | Nano And Advanced Materials Institute Limited | Nanoemulsion for transdermal delivery and method of making the same |
| IN2014CH01872A (es) | 2014-04-09 | 2015-05-08 | Nanoceutica Lab Pvt Ltd | |
| WO2016128858A1 (en) * | 2015-02-11 | 2016-08-18 | Towhidi Armin | Extender for cryopreservation of bovine sperm |
| WO2016182926A1 (en) * | 2015-05-08 | 2016-11-17 | Affinsci Inc. | Preparation of nanoemulsions |
| KR102669247B1 (ko) | 2015-05-21 | 2024-05-27 | 더마반트 사이언시즈 게엠베하 | 국소 제약 조성물 |
| US11617724B2 (en) | 2015-05-21 | 2023-04-04 | Dermavant Sciences GmbH | Topical pharmaceutical compositions |
| HUE054749T2 (hu) | 2015-06-30 | 2021-09-28 | Sequessome Tech Holdings Limited | Kevert készítmények |
| US10603508B2 (en) | 2015-10-15 | 2020-03-31 | Dusa Pharmaceuticals, Inc. | Adjustable illuminators and methods for photodynamic therapy and diagnosis |
| WO2017066270A1 (en) | 2015-10-15 | 2017-04-20 | Dusa Pharmaceuticals, Inc. | Adjustable illuminator for photodynamic therapy and diagnosis |
| GB201522398D0 (en) * | 2015-12-18 | 2016-02-03 | Photocure As | Device for photodynamic therapy |
| CN105997875B (zh) * | 2016-07-19 | 2019-05-21 | 重庆医科大学 | 一种明显提高难溶性药物生物利用度的油包水型纳米乳及其制备方法 |
| GB2546128A (en) * | 2016-09-28 | 2017-07-12 | Photocure Asa | Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same |
| BR112019010131A2 (pt) | 2016-11-21 | 2019-10-08 | Eirion Therapeutics, Inc. | entrega transdérmica de agentes grandes |
| JP7454492B2 (ja) * | 2017-07-17 | 2024-03-22 | デューサ ファーマシューティカルズ インコーポレイテッド | 皮膚障害に対する光線力学的治療方法 |
| CN107233303A (zh) * | 2017-08-07 | 2017-10-10 | 苏州纳美特生物科技有限公司 | 一种氨基酮戊酸冷霜及其制备方法和应用 |
| TWI719263B (zh) * | 2017-10-27 | 2021-02-21 | 財團法人國家衛生研究院 | 用於鼻黏膜之奈米級乳液免疫載劑及其製備方法 |
| US10959975B1 (en) * | 2017-11-02 | 2021-03-30 | The Tetra Corporation | Antifungal composition, method of making composition, and method of using composition |
| US10357567B1 (en) * | 2018-01-12 | 2019-07-23 | Dusa Pharmaceuticals, Inc. | Methods for photodynamic therapy |
| US20190358160A1 (en) * | 2018-05-11 | 2019-11-28 | Formulytica Pty Ltd | Sub-micron emulsions |
| EP3583954A1 (en) * | 2018-06-19 | 2019-12-25 | neubourg skin care GmbH | Nanodispersions of birch bark extract, electrospun fibers containing such nanodispersions and their use for the treatment of wounds |
| CN112584864A (zh) * | 2018-08-23 | 2021-03-30 | 生物前沿生物科学有限公司 | 包括两种不同波长的曝光的光动力疗法 |
| KR20210049159A (ko) * | 2018-08-31 | 2021-05-04 | 케민 인더스트리즈, 인코포레이티드 | 수분산성 인지질 및 리소인지질을 위한 기술 |
| WO2020135600A1 (zh) * | 2018-12-28 | 2020-07-02 | 南京善思生物科技有限公司 | 纳米农药制剂及其制备方法 |
| CN110169990A (zh) * | 2019-06-19 | 2019-08-27 | 苏普丘昆基蒂 | 牛至油治疗猪腹泻自乳化配方产品及制造工艺 |
| CN114081851A (zh) * | 2021-11-01 | 2022-02-25 | 苏州纳美特生物科技有限公司 | 保湿喷雾 |
| KR20250163360A (ko) * | 2023-04-06 | 2025-11-20 | 바이오프론테라 바이오사이언스 게엠베하 | 프로필렌 글리콜을 포함하지 않는 나노에멀젼 |
| WO2024208433A1 (en) | 2023-04-06 | 2024-10-10 | Biofrontera Bioscience Gmbh | Nanoemulsion without propylene glycol |
| WO2024209065A1 (en) * | 2023-04-06 | 2024-10-10 | Biofrontera Bioscience Gmbh | Pressurized nanoemulsion |
| WO2024208434A1 (en) * | 2023-04-06 | 2024-10-10 | Biofrontera Bioscience Gmbh | Pressurized nanoemulsion |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6165500A (en) * | 1990-08-24 | 2000-12-26 | Idea Ag | Preparation for the application of agents in mini-droplets |
| CA2117274A1 (en) * | 1993-04-14 | 1994-10-15 | Steven T. Adamy | Microemulsion cleaning composition comprising a glycol mono-alkylether |
| BR9504090A (pt) * | 1994-09-20 | 1996-09-24 | Johnson & Johnson | Composição farmacêutica transdermicamente ativante processo para sua preparação e método de tratar câncer |
| US5780010A (en) | 1995-06-08 | 1998-07-14 | Barnes-Jewish Hospital | Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system |
| SE9503143D0 (sv) | 1995-09-12 | 1995-09-12 | Astra Ab | New preparation |
| US6245349B1 (en) * | 1996-02-23 | 2001-06-12 | éLAN CORPORATION PLC | Drug delivery compositions suitable for intravenous injection |
| US5895786A (en) | 1996-05-08 | 1999-04-20 | New York Blood Center, Inc. | Method for treating viral infections |
| ATE229282T1 (de) | 1996-09-16 | 2002-12-15 | Nestle Sa | Essbare mikroemulsion zum beschichten von nahrungsmitteln, und verwendung zum bräunen und knusprig machen durch mikrowellen |
| ATE190469T1 (de) * | 1996-11-13 | 2000-04-15 | Procter & Gamble | Mikroemulsionsförmige desinfektionszusammensetzung |
| TWI241915B (en) * | 1998-05-11 | 2005-10-21 | Ciba Sc Holding Ag | A method of preparing a pharmaceutical end formulation using a nanodispersion |
| US6620437B2 (en) * | 1998-07-30 | 2003-09-16 | Colgate-Palmolive Co. | Water-in-oil microemulsion for providing cosmetic attributes to fabric softening base composition |
| DE19852245A1 (de) * | 1998-11-12 | 2000-05-18 | Asat Ag Applied Science & Tech | 5-Aminolävulinsäure-Nanoemulsion |
| FR2787728B1 (fr) * | 1998-12-23 | 2001-01-26 | Oreal | Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique |
| FR2787703B1 (fr) * | 1998-12-29 | 2001-01-26 | Oreal | Nanoemulsion a base d'ethers gras ethoxyles ou d'esters gras ethoxyles, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique |
| FR2788449B1 (fr) | 1999-01-14 | 2001-02-16 | Oreal | Nanoemulsion a base de citrates d'alkylether, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique |
| FR2795960B1 (fr) * | 1999-07-05 | 2001-10-19 | Sanofi Elf | Microemulsions stables pour l'administration d'acides gras a l'homme ou a l'animal, et utilisation de ces microemulsions |
| US7919113B2 (en) * | 1999-12-30 | 2011-04-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Dispersible concentrate lipospheres for delivery of active agents |
| DE10003620A1 (de) * | 2000-01-28 | 2001-08-02 | Asat Ag Applied Science & Tech | 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln |
| US20020155084A1 (en) * | 2000-06-02 | 2002-10-24 | The Regents Of The University Of The Michigan | Nanoemulsion formulations |
| US6823387B1 (en) * | 2000-06-23 | 2004-11-23 | Microsoft Corporation | System and method for enhancing a server's ability to withstand a “SYN flood” denial of service attack |
| EP1313448B1 (en) | 2000-08-16 | 2010-04-07 | The General Hospital Corporation doing business as Massachusetts General Hospital | Topical aminolevulinic acid-photodynamic therapy for acne vulgaris |
| JP2002302414A (ja) | 2000-12-26 | 2002-10-18 | Kokuriyuudou:Kk | スフィンゴ脂質構造物質含有乳化組成物及びその製造方法 |
| US7314624B2 (en) * | 2001-06-05 | 2008-01-01 | The Regents Of The University Of Michigan | Nanoemulsion vaccines |
| EP1434595A1 (en) * | 2001-10-05 | 2004-07-07 | Procyte Corporation | Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom |
| EP1467760A2 (en) | 2002-01-23 | 2004-10-20 | Light Sciences Corporation | Systems and methods for photodynamic therapy |
| JP2006505583A (ja) * | 2002-10-25 | 2006-02-16 | フォーミックス エルティーディー． | 化粧剤および医薬用フォーム |
| EP1473367B1 (en) * | 2003-04-17 | 2007-06-27 | Affectis Pharmaceuticals AG | Means and methods for diagnosing and treating affective disorders |
| US20050208083A1 (en) * | 2003-06-04 | 2005-09-22 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof |
| WO2005027872A2 (en) * | 2003-06-04 | 2005-03-31 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
| EP1598060A1 (en) * | 2004-05-18 | 2005-11-23 | Nestec S.A. | Oil-in-water emulsion for delivery |
| FR2872038A1 (fr) * | 2004-06-23 | 2005-12-30 | Rhodia Chimie Sa | Composition cosmetique comprenant un polyorganosiloxane et ses utilisations |
| TWI365075B (en) * | 2004-09-22 | 2012-06-01 | Kao Corp | Microemulsion |
| EP1655021B1 (en) * | 2004-11-09 | 2008-10-29 | Novagali Pharma SA | Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential |
| JP4444149B2 (ja) * | 2005-03-30 | 2010-03-31 | 株式会社ナリス化粧品 | 超微細エマルジョンで構成される皮膚外用剤 |
| KR100929264B1 (ko) * | 2005-04-28 | 2009-12-01 | 에스비아이 아라프로모 가부시키가이샤 | 피부외용제 |
| EP1938801A1 (en) * | 2006-12-22 | 2008-07-02 | Biofrontera Bioscience GmbH | Nanoemulsion |
-
2006
- 2006-12-22 EP EP06026698A patent/EP1938801A1/en not_active Ceased
-
2007
- 2007-12-20 CL CL2007003730A patent/CL2007003730A1/es unknown
- 2007-12-21 UA UAA200906344A patent/UA101471C2/ru unknown
- 2007-12-21 NZ NZ577061A patent/NZ577061A/en unknown
- 2007-12-21 MX MX2009006088A patent/MX2009006088A/es active IP Right Grant
- 2007-12-21 US US12/520,759 patent/US11540981B2/en active Active
- 2007-12-21 CN CN2007800474699A patent/CN101588792B/zh active Active
- 2007-12-21 EP EP07857110.6A patent/EP2120872B1/en active Active
- 2007-12-21 JP JP2009541922A patent/JP5558827B2/ja active Active
- 2007-12-21 ES ES07857110.6T patent/ES2602107T3/es active Active
- 2007-12-21 UY UY30833A patent/UY30833A1/es not_active Application Discontinuation
- 2007-12-21 CA CA2670715A patent/CA2670715C/en active Active
- 2007-12-21 RU RU2009128179/15A patent/RU2491917C2/ru active
- 2007-12-21 BR BRPI0720853-7A patent/BRPI0720853A2/pt not_active Application Discontinuation
- 2007-12-21 WO PCT/EP2007/011404 patent/WO2008077641A1/en not_active Ceased
- 2007-12-21 AU AU2007338323A patent/AU2007338323B2/en active Active
- 2007-12-21 AR ARP070105827A patent/AR064659A1/es not_active Application Discontinuation
-
2009
- 2009-05-20 ZA ZA2009/03468A patent/ZA200903468B/en unknown
- 2009-05-25 IL IL198934A patent/IL198934A/en active IP Right Grant
-
2022
- 2022-11-30 US US18/071,733 patent/US20230201087A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1938801A1 (en) | 2008-07-02 |
| BRPI0720853A2 (pt) | 2014-03-25 |
| IL198934A (en) | 2016-04-21 |
| EP2120872B1 (en) | 2016-09-21 |
| JP5558827B2 (ja) | 2014-07-23 |
| EP2120872A1 (en) | 2009-11-25 |
| US20090324727A1 (en) | 2009-12-31 |
| AU2007338323B2 (en) | 2013-07-11 |
| RU2491917C2 (ru) | 2013-09-10 |
| CA2670715C (en) | 2015-11-24 |
| CL2007003730A1 (es) | 2009-01-23 |
| ZA200903468B (en) | 2010-02-24 |
| CN101588792A (zh) | 2009-11-25 |
| IL198934A0 (en) | 2010-02-17 |
| NZ577061A (en) | 2012-01-12 |
| ES2602107T3 (es) | 2017-02-17 |
| WO2008077641A1 (en) | 2008-07-03 |
| CA2670715A1 (en) | 2008-07-03 |
| AU2007338323A1 (en) | 2008-07-03 |
| CN101588792B (zh) | 2012-03-21 |
| UY30833A1 (es) | 2008-07-31 |
| RU2009128179A (ru) | 2011-01-27 |
| US20230201087A1 (en) | 2023-06-29 |
| US11540981B2 (en) | 2023-01-03 |
| JP2010513363A (ja) | 2010-04-30 |
| AR064659A1 (es) | 2009-04-15 |
| UA101471C2 (en) | 2013-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009006088A (es) | Nanoemulsion. | |
| CL2013002550A1 (es) | Una formulacion farmaceutica inyectable subcutanea liquida estable altamente concentrada de un anticuerpo anti-her2 farmaceuticamente activo que consiste esencialmente de trastuzumab; his/hci un agente estabilizador y un surfactante no ionico; kit y su uso para tratar enfermedades tales como cancer (divisional de solicitud n°0269-2012). | |
| MX2008001503A (es) | Composicion cosmetica o dermatologica para la prevencion o el tratamiento de piel sensible o seca. | |
| MX2009000507A (es) | Espuma farmaceutica de acidos grasos. | |
| CU20130069A7 (es) | Derivados de 2,3-dihidroimidazo[1,2-c] quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermeddes asociadas a la angiogénesis | |
| EP3501546A3 (de) | Cystein-wirkstoff konjugate und ihre verwendung | |
| NZ618734A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| CL2009000035A1 (es) | Compuestos derivados 3-espiro-heterociclo-1il-5h-ciclopentan[d]pirimidin-indol, util para inhibir la actividad de akt quinasa; composicion farmaceutica que comprende dichos compuestos; y uso en el tratamiento de enfermedades tal como cancer, fibrosis quistica, diabetes, enfermedad de alzheimer, entre otras. | |
| EA201170876A1 (ru) | Применение способной к вспениванию композиции, по существу, не содержащей фармацевтически активные ингредиенты, для лечения кожи человека | |
| DOP2007000043A (es) | Derivados de cromanol sustituidos y su uso | |
| AR064149A1 (es) | Sal fumarato de (alfa s , beta r)-6 bromo- alfa-[ 2(dimetilamino ) etil)-2- metoxi - alfa-1-naftalenil- beta- fenil-3- quinolinaetanol | |
| MX2010004613A (es) | Composicion topica. | |
| UA110013C2 (uk) | Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів | |
| WO2012116990A3 (en) | Novel use | |
| WO2011059324A3 (en) | Composition for topical application, uses thereof, applicator device and kit of parts | |
| WO2009109654A8 (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1 | |
| AU2011208681A8 (en) | Aqueous solution comprising 3 - quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease | |
| NZ592429A (en) | PHENANTHROINDOLIZIDINE DERIVATIVE AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT | |
| WO2008046796A3 (en) | Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections | |
| UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
| WO2007113531A3 (en) | Topical drug delivery | |
| AR059225A1 (es) | Sal de citrato, proceso de preparacion y su actividad en terapia | |
| WO2007056236A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intravenously | |
| PL2004235T3 (pl) | Kompozycja do zastosowania kosmetycznego lub farmaceutyczno-dermatologicznego | |
| PL1868631T3 (pl) | Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general | ||
| FG | Grant or registration |